Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Antiviral Activities of Streptomyces KSF 103 Methanolic Extracts Against Dengue Virus Type-2

Version 1 : Received: 13 February 2023 / Approved: 15 February 2023 / Online: 15 February 2023 (01:51:33 CET)

How to cite: Zulkifli, N.; Khairat, J.E.; Azman, A.S.; Baharudin, N.M.; Malek, N.A.; Zainal Abidin, S.; Bakar, S.A.; Hassandarvish, P. Antiviral Activities of Streptomyces KSF 103 Methanolic Extracts Against Dengue Virus Type-2. Preprints 2023, 2023020247. https://doi.org/10.20944/preprints202302.0247.v1 Zulkifli, N.; Khairat, J.E.; Azman, A.S.; Baharudin, N.M.; Malek, N.A.; Zainal Abidin, S.; Bakar, S.A.; Hassandarvish, P. Antiviral Activities of Streptomyces KSF 103 Methanolic Extracts Against Dengue Virus Type-2. Preprints 2023, 2023020247. https://doi.org/10.20944/preprints202302.0247.v1

Abstract

Dengue has long been a serious health burden to the global community, especially for those living in the tropics. In spite of the availability of vaccines, effective treatment for the infection is still needed and currently remained absent. In the present study, antiviral properties of the KSF 103 ME which consisted of a number of potential antiviral compounds were investigated against DENV-2. The effects of this extract against DENV-2 replication were determined using the qRT-PCR. Findings from the study suggested that the KSF 103 ME showed maximum inhibitory properties toward the virus during the virus entry stage at concentrations of more than 12.5 µg/mL. Minimal antiviral activities were observed at other virus replication stages; adsorption (42% reduction at 50 µg/mL), post-adsorption (67.6% reduction at 50 µg/mL), prophylactic treatment (68.4% and 87.7% reductions at 50 µg/mL and 25 µg/mL, respectively) and direct virucidal assay (48% and 56.8% reductions at 50 µg/mL and 25 µg/mL, respectively. The KSF 103 ME inhibited dengue virus repication with an IC50 value of 20.3 µg/mL and SI value of 38.9. The KSF 103 ME showed potent antiviral properties against DENV during the entry stage. Further studies will be needed to deduce the antiviral mechanisms of the KSF 103 ME against DENV.

Keywords

Antivirals; arbovirus; dengue virus; Streptomyces; virus replication

Subject

Biology and Life Sciences, Virology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.